Healthcare | June 08, 2026
Awshad launches Calmagummies Gold to tap cannabis-based wellness market
Premium CBD+THC-infused gummies target stress relief, relaxation, and sleep recovery
Premium CBD+THC-infused gummies target stress relief, relaxation, and sleep recovery
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Targeting deadly drug-resistant acinetobacter infections
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
A total of 300 transgender individuals were screened as part of the study, with 82 identified as high-risk due to symptoms of anxiety, depression, and self-harm or suicidal tendencies
The move signals a major expansion in access to next-generation weight-loss therapies
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure
First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept
Subscribe To Our Newsletter & Stay Updated
